T2 Biosystems Announces Issuance of U.S. Patent for Direct
LEXINGTON, Mass., May 20, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) a leader in the rapid detection of sepsis-causing pathogens and...
Source: globenewswire.com
Page 7 - John Sperzel News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from John Sperzel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In John Sperzel Today - Breaking & Trending Today
Chembio Q1 Revenues More Than Double
Despite the revenue gains, the company said that there is substantial doubt about its ability to continue operations into 2023.
Source: 360dx.com
T2 Biosystems Announces BARDA Exercise of Contract Option
Advances U.S. Clinical Trials for T2Biothreat and T2Resistance and Continued Development of Next-Generation Diagnostics for the Detection of Bloodstream...
Source: globenewswire.com
T2 Biosystems Q4 Revenues Down 10 Percent, Beat Wall Street Expectations
The company's revenues for full-year 2021 were up 55 percent, however, on strong sales of its sepsis test panels.
Source: genomeweb.com
T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2021 Results
11.01.2022 - LEXINGTON, Mass., Jan. 11, 2022 (GLOBE NEWSWIRE) - T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced preliminary unaudited financial and operational results for the fourth quarter and ... Seite 1
Source: wallstreet-online.de